investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Randomized trial of 2 versus 3 doses of HPV vaccine in India
Rengaswamy Sankaranarayanan
0 Collaborator(s)
Funding source
Bill & Melinda Gates Foundation
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Ronald T Mitsuyasu
AIDS Malignancy Clinical Trials Consortium (AMC)
Cervix uteri
Michael Frumovitz
A Phase III Randomized Study of Pretherapeutic Para-aortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Dispositioned to Definitive Chemoradiotherapy
Cervix uteri
Radiation Oncology
Charles D Blanke
SWOG Network Group Operations Center of the NCTN
Cervix uteri
Global Noncommunicable Diseases Intiatives
Improving skills and institutional capacity to strengthen country adolescent immunisation programmes and health systems in the African Region
Cervix uteri
Investigator from Dolhay Klinika Egeszsegugyi Kft
Intimate, home-diagnostic tools for women
Cervix uteri
Global Noncommunicable Diseases Intiatives
Cryotherapy market dynamics: Increasing access to treatment of HPV-related disease - 2
Cervix uteri
Global Noncommunicable Diseases Intiatives
Centre for prevention of cervical cancer and infirmary for chemotherapeutic activities - 2
Cervix uteri
Kathleen Schmeler
NCI Pilot Collaborations with LMICs in Global Cancer Research at NCI-Designated Cancer Centers (P30 Supplement)
Cervix uteri
Philippe Mayaud
Evaluation and Impact of Screening and Treatment Approaches for the Prevention of Cervical Neoplasia in HIV-Positive Women in Burkina Faso and South Africa: Hpv in Africa Research Partnership
Cervix uteri
